ライフサイエンスコーパス: MTP

1 MTP deficiency had no effect on ceramide and sphingomyel

2 MTP deficiency significantly reduced triglyceride absorp

3 MTP inhibition in Western diet fed mice decreased plasma

4 MTP inhibition increases plasma transaminases and tissue

5 MTP inhibition is a valuable therapeutic approach for ho

6 MTP was covalently modified when cells were incubated wi

7 MTP was induced in fasted animals soon after refeeding.

8 MTP-131 also reduced total renal lysocardiolipin and maj

9 MTP-B does not encode a protein; MTP-C encodes the same

10 MTP-B has a unique first exon (Ex1B) located 10.5 kb ups

11 MTP-B represents approximately 90% of total MTP mRNA in

12 MTP-B was found in a number of tissues, whereas MTP-C wa

13 MTP-inhibited FTOCs produced negligible numbers of CD1d

14 MTPs and HTPs were sufficiently effective to decrease AP

15 5-MTP blocked cancer cell COX-2 overexpression and suppres

16 5-MTP levels decrease with progression of CKD, and in mous

17 5-MTP was synthesized from L-tryptophan via tryptophan hyd

18 9 and other cancer cells were defective in 5-MTP production.

19 droxylase-1 (TPH-1), an enzyme involved in 5-MTP synthesis, reduces renal injury by attenuating renal

20 etabolites, including 5-methoxytryptophan (5-MTP), whose levels strongly correlate with clinical mark

21 ryptophan metabolite, 5-methoxytryptophan (5-MTP).

22 Furthermore, i.p. infusion of 5-MTP reduced tumor growth and cancer metastasis in a muri

23 hat normal fibroblasts produce and release 5-MTP into the extracellular milieu whereas A549 and other

24 We conclude that 5-MTP synthesis represents a mechanism for endogenous cont

25 Treatment with 5-MTP ameliorates renal interstitial fibrosis, inhibits Ik

26 first exon (Ex1A) for canonical MTP (MTP-A); MTP-C contains both first exons for MTP-A and MTP-B.

27 tein-secreting cells, such as the adipocyte, MTP-B may have different localization properties, perhap

28 CCl(4) did not affect MTP synthesis but induced post-translational degradation

29 outinely generated from oleylamine-capped Ag MTPs, we obtained very few hollow structures by using a

30 When the size of Ag MTPs was increased to 14 nm, the SPR peak can be further

31 the same protein encoded by MTP-A, although MTP-C translation is strongly inhibited by regulatory el

32 s were randomized to be managed either by an MTP goal directed by TEG or by CCA (ie, international no

33 l trial (RCT) to test the hypothesis that an MTP goal directed by the viscoelastic assay thrombelasto

34 patients improves survival compared with an MTP guided by CCA and utilizes less plasma and platelet

35 phy (TEG) improves survival compared with an MTP guided by conventional coagulation assays (CCA).

36 TP-C contains both first exons for MTP-A and MTP-B.

37 e, we found that hepatic FoxO1 abundance and MTP production were increased in mice with abnormal trig

38 human tissues, which we have named MTP-B and MTP-C.

39 free cholesterol or triglyceride or both and MTP activity, specific inhibition of phospholipid or tri

40 egulating forkhead transcription factors and MTP and that inhibition of apoAIV expression might reduc

41 des were substantially lower in Gaa(-/-) and MTP mice vs. controls.

42 L production by regulating LysoPC levels and MTP expression.

43 vertase subtilisin/kexin type 9 (PCSK9), and MTP genes result in low or absent levels of apoB and LDL

44 4) decreased apoB-lipoprotein production and MTP activity but had no effect on mRNA levels in primary

45 he specific binding of substrates TPP(+) and MTP(+) to EmrE reconstituted into 1,2-dimyristoyl-sn-gly

46 ulation of MTP production and that augmented MTP levels may be a causative factor for VLDL overproduc

47 ctivities, and targeting of apolipoprotein B-MTP protein-protein interactions might be pursued to avo

48 f addressing the causal relationship between MTP inhibition and aberrant elevations in plasma liver e

49 The anti-LCN2 Ab-bound MTPs were stable for 6 weeks when stored in 0.1M PBS, pH

50 The anti-HFA Ab-bound MTPs, stored at 4 degrees C in 0.1M PBS, pH 7.4, retaine

51 The anti-HFA antibody-bound MTPs, stored at 4 degrees C in 0.1M PBS, were highly sta

52 n; MTP-C encodes the same protein encoded by MTP-A, although MTP-C translation is strongly inhibited

53 on CD4(+)CD8(+) FTOC cells was unaffected by MTP inhibition.

54 nti-tumor capabilities of our lead candidate MTP(10)-HDL in a B16F10 mouse melanoma model.

55 tream of the first exon (Ex1A) for canonical MTP (MTP-A); MTP-C contains both first exons for MTP-A a

56 ximately 2.7 kilobases upstream of canonical MTP (MTP-A) exon 1.

57 ion Facilitator/Metal Tolerance Protein (CDF/MTP) family of metal cation transporters in Oryza sativa

58 In HepG2 cells, MTP expression was induced by FoxO1 and inhibited by exp

59 MTP, FoxA2, and FoxO1 mRNA levels, cellular MTP activity, and media apoB.

60 cing plays a key role in regulating cellular MTP levels by introducing distinct promoter regions and

61 was evaluated and compared with a commercial MTP reader (MTPR) for three model assays: our recently d

62 ly, all extensor and flexor tendons crossing MTP joints demonstrated sheaths surrounding tendons.

63 Leptin decreased MTP expression in differentiated intestinal Caco-2 cells

64 treatment of chow diet-fed WT mice decreased MTP expression in the intestine, increased it in the liv

65 Finally, we determined MTP(10)-HDL's favorable biodistribution and safety profi

66 espectively, and thereby regulates divergent MTP expression.

67 The 2-carbonyl group of DK-MTP 1-P is rapidly hydrated and can undergo enolization

68 t studied the structure and reactivity of DK-MTP 1-P that was reported to decompose rapidly.

69 3-diketo-5-methylthiopentane 1-phosphate (DK-MTP 1-P) "enolase" reaction in the well-known "methionin

70 o confirm that this RuBisCO catalyzes the DK-MTP 1-P "enolase" reaction either in vitro or in vivo.

71 by abstraction of a proton from C1 of the DK-MTP 1-P substrate to form the tautomerized product, a co

72 th respect to distinct domains in Drosophila MTP (dMTP) and human MTP (hMTP) are not obvious because

73 Previously we reported that the Drosophila MTP transfers phospholipids but does not transfer trigly

74 Elamipretide (MTP-131), a novel mitochondria-targeting peptide, was sh

75 FoxO1 activity was associated with enhanced MTP expression, augmented VLDL production, and elevated

76 All of the analogues, except MTP, and their products were substrates for the three co

77 n mice were subjected to restricted feeding, MTP expression was high at the expected time of food ava

78 c level-1 trauma center meeting criteria for MTP activation.

79 (MTP-A); MTP-C contains both first exons for MTP-A and MTP-B.

80 d formin 1 (DIAPH1), as a candidate gene for MTP using exome sequencing, ontological phenotyping, and

81 Liver and enterocyte microsomes from MTP-deficient animals synthesize lesser amounts of chole

82 The antibody-bound GNP-functionalized MTPs retained its original activity after 6 weeks of sto

83 Furthermore, MTP(10)-HDL nanotherapy potentiates checkpoint inhibitio

84 Utilization of a goal-directed, TEG-guided MTP to resuscitate severely injured patients improves su

85 . investigate the events controlling hepatic MTP expression and VLDL production and secretion (see th

86 Similar to the small intestine, hepatic MTP activity, protein, and mRNA levels also changed sign

87 the underlying mechanism, we studied hepatic MTP regulation by forkhead box O1 (FoxO1), a transcripti

88 These data highlight MTP as a unique regulator of human metabolic and immune

89 At higher concentrations, however, MTP inhibitors blocked apoE expression and secretion and

90 aphragmatic contractile properties; however, MTP mice had ventilation similar to the Gaa(-/-) mice du

91 t domains in Drosophila MTP (dMTP) and human MTP (hMTP) are not obvious because both proteins have ve

92 Splice variants of human MTP have not been reported.

93 We identified MTP variant 1 (MTPv1), a novel splice variant of mouse M

94 These studies identify MTP as a major target of CCl(4) and its degradation as a

95 Replacement with a low dose of CORT in MTP-treated animals reversed these effects in brain.

96 ro-interfering RNA led to 60-70% decrease in MTP mRNA and protein levels, but it had no detectable ef

97 It is associated with defects in MTP-mediated lipid transfer onto apolipoprotein B (APOB)

98 nemia patients with deleterious mutations in MTP and absence of B-lps had significantly lower plasma

99 Characterization of mutations in MTP causing abetalipoproteinemia has revealed that the c

100 es its degradation, leading to reductions in MTP activity and in apolipoprotein B (APOB) secretion.

101 and dark completely abolished rhythmicity in MTP expression and plasma lipid levels.

102 as food and light, play an important role in MTP regulation.

103 Diurnal variations in MTP expression and its induction by food availability ha

104 cted with short-form LEPR (ObRa) to increase MTP expression.

105 Moreover, LysoPC increased MTP mRNA, protein, and activity.

106 Conversely, apoAIV overexpression increased MTP mRNA in hepatoma cells, indicating transcriptional r

107 t of therapies for dyslipidemia that inhibit MTP.

108 Adenoviral overexpression of SHP inhibits MTP activity as well as VLDL-apoB protein secretion, and

109 nses, we measured MTP expression; intestinal MTP was low at night, and its induction after food entra

110 These studies show that intestinal MTP and ABCA1 are critical for lipid absorption and are

111 This isoform, MTP-B, has a unique first exon located approximately 2.7

112 noviruses in liver-specific MTP-deficient (L-MTP(-/-)) mice that have low plasma and high hepatic lip

113 Hepatosteatosis in L-MTP(-/-) mice was ameliorated to similar levels by both.

114 other pathways, we generated mice that lack MTP and ABCA1, individually and in combination, in the i

115 e--the Gaa(-/-) mouse and a transgenic line (MTP) expressing GAA only in skeletal muscle, as well as

116 We further speculate that short-lived MTP antagonists may be useful in controlling plasma and

117 and high-temperature pasteurisations (LTPs, MTPs and HTPs): 65, 80 and 90 degrees C for 30 or 60s.

118 Macrothrombocytopenia (MTP) is a heterogeneous group of disorders characterized

119 NOD2 received intravitreal injection of MDP, MTP, or PGN.

120 asons for these lower responses, we measured MTP expression; intestinal MTP was low at night, and its

121 of FoxA2 and FoxO1 abolished apoAIV-mediated MTP induction.

122 results also indicated that leptin-mediated MTP regulation in the intestine affects plasma lipid lev

123 tected tenosynovitis at metatarsophalangeal (MTP) joints and RA.

124 ted with the VPT at the metatarsophalangeal (MTP) joint (Spearman's rho=0.384, P=0.033), indicating t

125 rticosteroid synthesis inhibitor metyrapone (MTP) also significantly reduced GR-ir in the POA, mp, Me

126 In most MTP, this phenotype arises because of altered regulation

127 t 1 (MTPv1), a novel splice variant of mouse MTP, by polymerase chain reaction and Northern analysis

128 ely 2.7 kilobases upstream of canonical MTP (MTP-A) exon 1.

129 of the first exon (Ex1A) for canonical MTP (MTP-A); MTP-C contains both first exons for MTP-A and MT

130 riants in human tissues, which we have named MTP-B and MTP-C.

131 red with 20 amino acids encoded by exon 1 of MTP-A.

132 Ablation of MTP abolishes triglyceride absorption and results in mas

133 Conditional genetic ablation of MTP reduces cholesteryl esters and enhances free cholest

134 epatic iNKT cell abundance in the absence of MTP is associated with susceptibility to severe iNKT cel

135 regulate FoxO1 transcriptional activation of MTP.

136 utral and polar lipid transfer activities of MTP are critical for lipoprotein assembly.

137 nce of the phospholipid transfer activity of MTP in the lipidation of apolipoprotein B and CD1d has b

138 Phospholipid transfer activity of MTP promoted biogenesis of both apoB48 and apoB100-conta

139 ibition of triglyceride transfer activity of MTP.

140 trend toward better EFS with the addition of MTP (P = .08).

141 The addition of MTP to chemotherapy improved 6-year overall survival fro

142 The addition of MTP to chemotherapy resulted in a statistically signific

143 io for overall survival with the addition of MTP was 0.71 (95% CI, 0.52 to 0.96).

144 tion, and urinary H(2)O(2) Administration of MTP-131 significantly inhibited increases in albuminuria

145 cific regions corresponding to the bottom of MTP's wells.

146 Conversely, coexpression of MTP and apoB in AC29 cells stably transfected with ACAT1

147 Furthermore, the combination of MTP-PE and IFN-gamma on AML blasts generated an inflamma

148 Yet, the development of MTP inhibitors to lower plasma lipid concentrations has

149 Thus, the N-terminal domain of MTP is also important for its lipid transfer activity.

150 1B is quite adequate to drive expression of MTP.

151 A new function of MTP in cholesterol ester biosynthesis has been reported.

152 ve knowledge about the structure-function of MTP might help design new molecules that avoid steatosis

153 lated primary hepatocytes, heterozygosity of MTP caused an approximately 50% reduction in mitochondri

154 However, we found that the major impact of MTP deficiency occurred distal to the ER and Golgi compa

155 lipoprotein assembly occur independently of MTP lipid transfer activity.

156 lso reduces lipid synthesis independently of MTP.

157 apoE expression, as well as the influence of MTP inhibitors on the formation of HCV particles.

158 Chemical inhibition of MTP also decreases esterification of cholesterol in Caco

159 s, we posit that the selective inhibition of MTP triglyceride transfer activity might reduce hyperlip

160 Intestine-specific inhibitors of MTP decrease chylomicron biogenesis and improve insulin

161 Mice with hepatocyte-specific loss of MTP exhibit defects in the function of CD1d and show inc

162 understanding of the molecular mechanisms of MTP has been hindered by a lack of structural informatio

163 Cotranslational presence of MTP can dramatically promote the folding of B6.4-20.5 an

164 The presence of MTP prolongs this window of time by acting as a chaperon

165 thermore, apoB translated in the presence of MTP retains its phospholipid recruitment capability post

166 Adenovirus-mediated reconstitution of MTP expression proportionately restored CREBH processing

167 interacts with the 3' untranslated region of MTP mRNA and induces its degradation, leading to reducti

168 of the biology and therapeutic regulation of MTP and their significance for lipid metabolism and card

169 abolition of insulin-dependent regulation of MTP expression.

170 st that FoxO1 mediates insulin regulation of MTP production and that augmented MTP levels may be a ca

171 d as a novel intestine-specific regulator of MTP.

172 roRNA-30c (miR-30c) as a potent repressor of MTP that controls plasma apoB-containing lipoprotein lev

173 investigated the putative functional role of MTP in the initial lipidation of apoB:1000 in stable tra

174 The structure of MTP presented here gives important insights into the pot

175 ent, participants with the LCHADD subtype of MTP disorder continue to demonstrate visually disabling

176 Suppression of MTP gene expression in stable transformants of McA-RH777

177 However, the clinical use of MTP inhibitors has been uncertain because of the gastroi

178 identification of a novel splice variant of MTP in mice.

179 udies in mice identified a splice variant of MTP with an alternate first exon.

180 d in vivo virulence suggest the potential of MTPs as promising drug targets.

181 and this process is critically dependent on MTP.

182 sought to identify the effects of leptin on MTP expression in the intestine and liver.

183 To study the effect of this mutation on MTP function, we created mutants via site-directed mutag

184 on efficiency, enabling the cell to optimize MTP activity.

185 receive or not to receive ifosfamide and/or MTP in a 2 x 2 factorial design.

186 absence of either proper lipid substrate or MTP may result in the improper folding of apoB and, cons

187 Partial MTP inhibition using small molecule inhibitors, such as

188 (BES) derived from three minimum tile paths (MTP) to examine the extent and homogeneity of polyploid-

189 dendritic cells isolated from ABL patients, MTP deficiency was associated with increased proteasomal

190 ncept that mitochondrial targeting peptides (MTP) can interact and disrupt bacterial membranes, actin

191 sphate (EP), D-3-methylthrietol-4-phosphate (MTP), D-3-ethylerythritol-4-phosphate (EEP), D-1-amino-3

192 muramyl tripeptide phosphatidylethanolamine (MTP-PE), a synthetic ligand for NOD2.

193 amily of mannosyltransferase/phosphorylases (MTPs) newly discovered by Sernee et al.

194 activity mannosyltransferase/phosphorylases (MTPs) that catalyze both the sugar nucleotide-dependent

195 Purified M. tuberculosis pili (MTP) are composed of low-molecular-weight protein subuni

196 A 96- or 24-well microtiter plate (MTP) was positioned on the gadget's screensaver that pro

197 hed to a polystyrene based-microtiter plate (MTP), pretreated with KOH.

198 pensed in a KOH-pretreated microtiter plate (MTP).

199 ve cellphone-based 96-well microtiter-plate (MTP) reader, capable of performing AST without the need

200 anomagnetic bead, and microwell ELISA plate, MTP-p53Ag/BSA were compared.

201 96-well chemiluminescent microtiter plates (MTP) using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimid

202 osterior (ITP) > medium turbinate posterior (MTP) > medium turbinate anterior (MTA).

203 As predicted, a decrease in spectral power (MTP) at 40 Hz was observed in the cannabis group (p<0.01

204 formed using Fourier-based mean trial power (MTP) and phase-locking (inter-trial coherence; ITC).

205 formed using Fourier-based mean trial power (MTP).

206 and the role of a mitochondrial protectant, MTP-131 (also called elamipretide, SS-31, or Bendavia) i

207 nd, microsomal triglycerol transfer protein (MTP) activity and apolipoprotein B (ApoB) secretion were

208 in microsomal triglyceride transfer protein (MTP) activity, hepatic TG content increased dramatically

209 ested that both microsomal transfer protein (MTP) and apoB are important for HCV production.

210 on microsomal triglyceride transfer protein (MTP) and ATP-binding cassette family A protein 1, respec

211 of microsomal triglyceride transfer protein (MTP) and ATP-binding cassette transporter A1 (ABCA1) in

212 by microsomal triglyceride transfer protein (MTP) in a rate-limiting step that is regulated by insuli

213 A microsomal triglyceride transfer protein (MTP) inhibitor nearly deleted apoB100 secretion from hep

214 a microsomal triglyceride transfer protein (MTP) inhibitor to block beta-lipoprotein particle format

215 of microsomal triglyceride transfer protein (MTP) inhibitors is limited to severe hyperlipidemias bec

216 Microsomal triglyceride transfer protein (MTP) is a key protein in the secretion of apolipoprotein

217 Microsomal triglyceride transfer protein (MTP) is a target to reduce plasma lipids because of its

218 Microsomal triglyceride transfer protein (MTP) is a unique lipid transfer protein essential for th

219 Microsomal triglyceride transfer protein (MTP) is an endoplasmic reticulum (ER)-resident lipid tra

220 er microsomal triglyceride transfer protein (MTP) mRNA and protein levels.

221 Microsomal triglyceride transfer protein (MTP) plays a key role in the lipidation of nascent apoB

222 Microsomal triglyceride transfer protein (MTP) plays an essential role in lipid metabolism, especi

223 ed microsomal triglyceride transfer protein (MTP) without diminishing mRNA levels.

224 Microsomal triglyceride transfer protein (MTP), a chaperone for the biosynthesis of apolipoprotein

225 at microsomal triglyceride transfer protein (MTP), a protein involved in the transfer of lipids onto

226 Microsomal triglyceride transfer protein (MTP), an endoplasmic reticulum lipid transfer protein cr

227 k, microsomal triglyceride transfer protein (MTP), and nocturnin are involved in the circadian regula

228 or microsomal triglyceride transfer protein (MTP), as well as deletion of HSP110 in the radioresistan

229 on microsomal triglyceride transfer protein (MTP), can contribute to hyperlipidemia.

230 Microsomal triglyceride transfer protein (MTP), essential for apolipoprotein B (apoB) biosynthesis

231 to the ER by microsomal TG transfer protein (MTP), inducing ER stress.

232 e, microsomal triglyceride transfer protein (MTP), is required for the biosynthesis of these lipoprot

233 of microsomal triglyceride transfer protein (MTP), required for B-lp assembly and secretion, in sphin

234 he microsomal triglyceride transfer protein (MTP), the product of the MTTP gene, is essential for the

235 in microsomal triglyceride transfer protein (MTP).

236 nd microsomal triglyceride transfer protein (MTP).

237 by microsomal triglyceride transfer protein (MTP).

238 on microsomal triglyceride transfer protein (MTP).

239 or microsomal triglyceride transfer protein (MTP).

240 ) for a mitochondrial trifunctional protein (MTP) gene defect to determine if a primary defect in mit

241 such as mitochondrial trifunctional protein (MTP) that catalyses beta-oxidation of fatty acids in L.

242 of the mitochondrial trifunctional protein (MTP), an enzyme complex which catalyzes the last 3 steps

243 MTP-B does not encode a protein; MTP-C encodes the same protein encoded by MTP-A, althoug

244 Metal tolerance proteins (MTPs) are plant members of the cation diffusion facilita

245 Massive transfusion protocols (MTPs) have become standard of care in the management of

246 yl esters in vitro, but addition of purified MTP and low density lipoprotein corrects this deficiency

247 Recently, MTP was shown to regulate the CD1 family of lipid antige

248 poAIV in differentiated Caco-2 cells reduced MTP, FoxA2, and FoxO1 mRNA levels, cellular MTP activity

249 of hepatic FoxO1 was associated with reduced MTP and VLDL production in adult mice.

250 expressed in the intestine, to down-regulate MTP.

251 , our findings suggest that leptin regulates MTP expression differentially by engaging with different

252 The seven MTPs catalyze the constitutive synthesis and turnover of

253 s were seen in liver- and intestine-specific MTP knock-out (L,I-Mttp(-/-)) mice, suggesting that MTP

254 ing and apoA-IV expression in liver-specific MTP knock-out mice.

255 thologs using adenoviruses in liver-specific MTP-deficient (L-MTP(-/-)) mice that have low plasma and

256 h the ability of FoxO1 to bind and stimulate MTP promoter activity.

257 Lomitapide, a systemic MTP inhibitor, significantly reduces LDL-C in homozygous

258 renal and cardiac superoxide levels and that MTP-131 protects against DKD and preserves physiological

259 We conclude that MTP-B functions similarly to MTP-A in lipoprotein assemb

260 We confirmed that MTP mice had normal diaphragmatic contractile properties

261 They demonstrate that MTP is a target of the transcription factor FoxO1 and th

262 We also found that MTP transferred these lipids between vesicles in vitro.

263 We hypothesized that MTP deficiency may affect either their synthesis or secr

264 Thus, we propose that MTP are previously unidentified host-colonization factor

265 Therefore, we propose that MTP might regulate plasma ceramide and sphingomyelin lev

266 Mechanistic studies revealed that MTP inhibition increased transcription of the GPT/GOT1 g

267 The proposed approaches may show that MTP targeting is a viable approach to lower plasma lipid

268 A loss-of-function study showed that MTP depletion rendered cells less responsive to alpha in

269 Gene-ablation studies showed that MTP function and chylomicron assembly is essential for t

270 ck-out (L,I-Mttp(-/-)) mice, suggesting that MTP specifically plays a role in the regulation of plasm

271 The MTP (minimal tiling path) module uses sequence and finge

272 was directly associated with the VPT at the MTP joint and lateral femoral condyle, after adjustment

273 Simulation results are provided for the MTP, DSI and parallelization.

274 ne attachment that holds and illuminates the MTP using a light-emitting-diode array.

275 inding to the identified cis elements in the MTP promoter at night.

276 d that sequences between -204/-775 bp in the MTP promoter respond to apoAIV and that apoAIV enhances

277 st that the acquisition and expansion of the MTP family in Leishmania increased the metabolic flexibi

278 mutation of the FoxO1 target site within the MTP promoter disabled FoxO1 binding and resulted in abol

279 and phylogenic analysis shows that while the MTPs are structurally related to bacterial mannan phosph

280 Therefore, MTP is involved in ceramide and sphingomyelin secretion

281 Therefore, MTP plays a novel role in regulating cholesteryl ester b

282 Therefore, MTPs represent alternative sources to design new potenti

283 Consistently with this, MTP protein and mRNA levels were suppressed by HCV infec

284 Thus, MTP enhances cellular cholesterol esterification by remo

285 abolished ocular inflammation in response to MTP but not to PGN treatment.

286 e conclude that MTP-B functions similarly to MTP-A in lipoprotein assembly.

287 MTP-B represents approximately 90% of total MTP mRNA in mouse adipocytes and 3T3-L1 cells and <5% in

288 whether the addition of muramyl tripeptide (MTP) to chemotherapy enhances event-free survival (EFS)

289 amyl dipeptide (MDP) and muramyl tripeptide (MTP).

290 Additionally, two MTP inhibitors, CP-346086 and BMS-2101038, efficiently b

291 participants all underwent MRI of unilateral MTP joints 1-5.

292 Upon MTP activation, patients were randomized to be managed e

293 We tested this mobile-reader using MTPs prepared with 17 antibiotics targeting Gram-negativ

294 of ABCA1, and it was reduced by 92-95% when MTP was deleted in the intestine alone or together with

295 t affecting lipid transfer activity, whereas MTP antagonist inhibits lipid transfer activity without

296 -B was found in a number of tissues, whereas MTP-C was prominent in brain and testis.

297 But it is unknown whether MTP directly transfers lipids onto apoB in vivo and, if

298 onsequently absence of Ufm1 conjugation with MTP resulted in diminished acetyl-CoA, the end-product o

299 We describe 2 unrelated pedigrees with MTP and sensorineural hearing loss that segregate with a

300 tal thymic organ culture (FTOC) treated with MTP antagonists.

301 n a murine model of AML, dual treatment with MTP-PE and IFN-gamma led to a significant increase in ma